Skip to main content

Published locations for Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indications

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indications

User login

  • Reset your password
  • /content/immunotherapy-treated-nsclc-adverse-impact-steroids-driven-palliative-indications
  • /fedprac/article/203431/lung-cancer/immunotherapy-treated-nsclc-adverse-impact-steroids-driven
  • /oncologypractice/article/203431/lung-cancer/immunotherapy-treated-nsclc-adverse-impact-steroids
  • /fedprac/avaho/article/203431/lung-cancer/immunotherapy-treated-nsclc-adverse-impact-steroids-driven
  • /hematology-oncology/article/203431/lung-cancer/immunotherapy-treated-nsclc-adverse-impact-steroids
  • /chestphysician/article/203431/lung-cancer/immunotherapy-treated-nsclc-adverse-impact-steroids-driven